[email protected]

现代护理医学杂志

Journal of Modern Nursing Medicine

您当前位置:首页 > 精选文章

Journal of Modern Nursing Medicine. 2025; 4: (12) ; 10.12208/j.jmnm.20250609 .

Research progress on common complications and clinical nursing of elderly patients with liver cancer after hepatic artery catheter chemotherapy embolization
老年肝癌患者经肝动脉插管化疗栓塞术后常见并发症及临床护理研究进展

作者: 李锦 *

中国人民解放军陆军特色医学中心 重庆

*通讯作者: 李锦,单位:中国人民解放军陆军特色医学中心 重庆;

引用本文: 李锦 老年肝癌患者经肝动脉插管化疗栓塞术后常见并发症及临床护理研究进展[J]. 现代护理医学杂志, 2025; 4: (12) : 5-7.
Published: 2025/12/17 9:35:05

摘要

老年肝癌患者行肝动脉插管化疗栓塞术(TACE)后,因机体功能衰退、基础疾病多等因素,并发症发生率较高,本文系统梳理术后常见并发症,包括肝肾功能损伤、穿刺部位异常、胃肠道反应、感染及血栓形成等,结合老年患者生理病理特点,深入剖析其发生机制,总结针对各类并发症的临床护理策略,从病情监测、症状干预到康复指导等多维度阐述护理要点,旨在为提升老年肝癌患者TACE术后护理质量提供参考。

关键词: 老年肝癌;肝动脉插管化疗栓塞术;并发症;研究进展

Abstract

After undergoing transcatheter arterial chemoembolization (TACE) for liver cancer in the elderly, patients often experience a higher incidence of complications due to the decline in bodily functions and the presence of multiple underlying conditions. This article systematically reviews common postoperative complications, including liver and kidney damage, puncture site abnormalities, gastrointestinal reactions, infections, and thrombosis. By considering the physiological and pathological characteristics of elderly patients, it delves into the mechanisms behind these complications and summarizes clinical nursing strategies for managing each type. The article outlines key nursing points from multiple dimensions, including condition monitoring, symptom management, and rehabilitation guidance, aiming to enhance the quality of TACE postoperative care for elderly liver cancer patients.

Key words: Elderly liver cancer; Hepatic artery catheter chemotherapy embolization; Complications; Research progress

参考文献 References

[1] 颜幸杰,李柳梅,陈玉娟,等.参芪三甲汤联合经肝动脉插管化疗栓塞术对原发性肝癌患者相关指标及Child-Pugh分级的影响[J].实用临床医药杂志,2023,27(10):46-50.

[2] 曾敬科,王水根,吕述华,等.三维可视化辅助经肝动脉插管化疗栓塞术联合微波消融治疗中晚期肝癌的临床研究[J].当代医学,2024,30(2):46-50.

[3] 宋然,郑雅各.仑伐替尼联合肝动脉插管化疗栓塞术治疗不可切除晚期肝癌的疗效及生存率影响因素分析[J].中华消化病与影像杂志电子版,2025,15(02):120-124.

[4] 郑本波,刘航,黄文,等.临界可切除肝癌行肝动脉灌注化疗联合肝动脉栓塞术转化治疗的疗效[J].中国普通外科杂志,2024,33(1):36-43.

[5] 张利捷,李卿,张鑫.经尾动脉与胃十二指肠动脉行大鼠肝动脉插管的对比研究[J].Diagnostic Imaging& Interventional Radiology,2024,33(5).

[6] 张惠东,庄文行,余国芳.miR-200a,AFP-L3和NLR在接受肝动脉插管化疗栓塞术治疗的肝癌患者中的临床意义及预后的相关性[J].临床和实验医学杂志,2024, 23(20): 2176-2180.

[7] 陈志文,高恒毅.肝动脉插管化疗栓塞术+仑伐替尼+程序性死亡受体1联合治疗对不可切除肝癌的影响[J].中国医学工程,2024,32(6):65-69.

[8] 李海伟.肝动脉插管化疗栓塞联合选择性门静脉栓塞后手术切除治疗大肝癌的疗效[J].现代诊断与治疗,2023, 34(2):273-276.

[9] 李榕,李文利,袁国盛.肝动脉灌注化疗术联合靶免对比经动脉插管化疗栓塞术联合靶免治疗中晚期肝癌患者术后引起肝损伤的研究[J].中华肝脏病杂志,2023,31(11): 1163-1168.

[10] 李鹏飞,张珈晨,郑瑞鹏,等.进展期肝癌TACE动脉插管:经股动脉/左远桡动脉入路对照评价[J].中国实验诊断学, 2024, 28(4):426-428.

[11] 蒋政,温凯淋,查煌旗,等.比较肝动脉插管化疗栓塞术与肝动脉灌注化疗术在原发性肝癌患者治疗中的应用效果及安全性[J].临床普外科电子杂志, 2025, 13(1):21-24, 88.

[12] 陈枫.瑞戈非尼联合微波消融,肝动脉插管化疗栓塞术治疗原发性肝癌的效果[J].临床普外科电子杂志, 2024, 12(4): 16-21.